About US
Contact us
-
Ex-Heritage Pharma execs first up for federal charges in generics price-fixing probeJust a month after details of a wide-ranging generics price fixing probe made their way to the public, the Justice Department has stepped forward with its first charges. Prosecutors are determined the2017/1/13
-
Bristol-Myers to pay $19.5 million in Abilify off-label marketing settlementAlmost a decade after settling up Abilify marketing allegations with the U.S. Justice Department, Bristol-Myers Squibb agreed to pay $19.5 million to settle similar claims at the state level. Announc2017/1/12
-
Trump wants to battle high drug prices? Let's work together, hike-fighting senator saysSen. Amy Klobuchar, who early on called for an investigation into Mylan’s EpiPen prices, has a message for President-elect Donald Trump: Let’s bring drug prices down together. In a newop-edfor USA2017/1/12
-
Zetia generics launch sets Merck up for $1.4B hit to 2017 cholesterol salesMerck & Co.'s big-selling cholesterol-fighter Zetia is at the end of its exclusive road. The $2.5 billion sellernow faces its first generic competitor, which threatens not only its own revenue, bu2017/1/11
-
Once-spurned cancer drugs win NICE's favor with—no surprise—'sensible pricing'England’s cost-effectiveness watchdogs are a tough audience, and they've often angered cancer drugmakers when meds were turned away. Recently, however, a steady stream of oncology meds have made it th2017/1/11
-
Ex-VP sues Bayer, saying she defended a pregnant colleague and got whacked for itPreviously Bayer’s “Working Mother of the Year,” former vice president Irene Laurora has sued the Big Pharma, allegingshe was mistreatedafter she stood up for a pregnant colleague. Laurora’s lawsuit2017/1/10
-
Rest easy, pharma. AstraZeneca, Ranbaxy prevailed in landmark pay-for-delay caseIn 2013, it looked as if AstraZeneca and Ranbaxy couldface billionsin damages in a lawsuit alleging they struck an illegal deal to block a generic of the blockbuster heartburn remedy Nexium. Now that2017/1/10
-
The Top Three International Regulatory Compliance ChallengesThe challenge of complying with supply chain regulations is now greater than ever. Legislators around the world have responded to the risks posed to healthcare supply chains with new requirements. T2017/1/9
-
EpiPen maker Mylan, U.S. officials stiff-arm senator's call to testify on DOJ settlementU.S. lawmakers are still trying to hold Mylan accountable for its controversial EpiPen price hikes. But the company now flatly refuses to testify at a committee hearing convened by Sen. Charles Grassl2017/1/9
-
Who owns 'moonshot'? MD Anderson says it does in suit against biotech billionaire Soon-ShiongFor years, the University of Texas’ MD Anderson Cancer Center has used the Cancer Moonshot tagline without any challengers. That is, until two separate programs with similar names came along earlier t2017/1/6